the use of high-dose Advair for COPD
April 2007
Glaxo will promote the use of high-dose Advair for COPD.
This is based on a new study comparing the combination of fluticasone and salmeterol (Advair) to salmeterol alone (Serevent).
It shows that high-dose Advair is better than Serevent in reducing exacerbations and the need for systemic steroids.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive